Acylurea derivatives
US5576334A · kind A · utility
2Cited by
7References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 27, 1994 |
| Grant date | Nov 19, 1996 |
| Priority date | — |
| Expiry date | Jun 27, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D295/15
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention concerns chemical compounds of formula I EQU R.sup.1 --CON(R.sup.2)--CON(R.sup.3)--X.sup.1 --Q--X.sup.2 --GI and pharmaceutically acceptable metabolically labile esters or amides thereof, and pharmaceutically acceptable salts thereof, in which R.sup.1, R.sup.2, R.sup.3, X.sup.1, Q, X.sup.2 and G have the meanings given in the specification. The invention concerns processes for the preparation of the chemical compounds of formula I, pharmaceutical compositions containing them and their use as inhibitors of the binding of fibrinogen to glycoprotein IIb/IIIa.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.